Testosterone and cardiovascular risk

Internal and Emergency Medicine

Volumn 8, Issue SUPPL. 1, 2013, Pages 65-69

  Tirabassi, Giacomo ^a   Gioia, Angelo ^a   Giovannini, Lara ^a   Boscaro, Marco ^a   Corona, Giovanni ^b,d   Carpi, Angelo ^c   Maggi, Mario ^d   Balercia, Giancarlo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiovascular risk; Hypogonadism; Male sex; Testosterone

Indexed keywords

EID: 84875651092     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0914-1     Document Type: Review

References (25)

1. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M (2011) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 25: 337-353. doi: 10. 1016/j. beem. 2010. 07. 002.
2. Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, Maggi M (2011) Hypogonadism and metabolic syndrome. J Endocrinol Invest 34: 557-567. doi: 10. 3275/7806.
3. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M (2011) Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 8: 272-283. doi: 10. 1111/j. 1743-6109. 2010. 01991. x.
4. Zizzi A, Tirabassi G, Aspriello SD, Piemontese M, Rubini C, Lucarini G (2012) Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study. J Periodontal Res. doi: 10. 1111/jre. 12007.
5. Marcellini F, Giuli C, Papa R, Tirabassi G, Faloia E, Boscaro M, Polito A, Ciarapica D, Zaccaria M, Mocchegiani E (2009) Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. Arch Gerontol Geriatr 49(Suppl 1): 195-206. doi: 10. 1016/j. archger. 2009. 09. 029.
6. Faloia E, Tirabassi G, Canibus P, Boscaro M (2009) Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women. Nutr Metab Cardiovasc Dis 19: 39-44. doi: 10. 1016/j. numecd. 2008. 02. 004.
7. Phillips GB, Castelli WP, Abbott RD, McNamara PM (1983) Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med 74: 863-869.
8. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS (2000) Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 21: 890-894.
9. Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C, Mercuro G, Volterrani M, Aversa A, Fini M (2007) Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 19: 176-182.
10. Jeppesen LL, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS, Winther K (1996) Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol 16: 749-754.
11. Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K, Flicker L, Hankey GJ (2009) Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 94: 2353-2359. doi: 10. 1210/jc. 2008-2416.
12. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 116: 2694-2701.
13. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M (2010) Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med. 7: 1557-1564. doi: 10. 1111/j. 1743-6109. 2009. 01690. x.
14. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M (2011) Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 165: 687-701. doi: 10. 1530/EJE-11-0447.
15. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA (2011) Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 3007-3019. doi: 10. 1210/jc. 2011-1137.
16. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54: 919-927. doi: 10. 1016/j. jacc. 2009. 04. 078.
17. Webb CM, Adamson DL, de Zeigler D, Collins P (1999) Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 83: 437-439.
18. Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281: 1720-1727.
19. Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS (2002) Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 39: 814-823.
20. Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A (2006) Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J Endocrinol 189: 595-604.
21. Nettleship JE, Jones TH, Channer KS, Jones RD (2007) Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor. Circulation 116: 2427-2434.
22. Tharp DL, Masseau I, Ivey J, Ganjam VK, Bowles DK (2009) Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine. Cardiovasc Res 82: 152-160. doi: 10. 1093/cvr/cvp038.
23. Maddali KK, Korzick DH, Tharp DL, Bowles DK (2005) PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1. 2. J Biol Chem 280: 43024-43029.
24. Jin H, Lin J, Fu L, Mei YF, Peng G, Tan X, Wang DM, Wang W, Li YG (2007) Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells. Biochem Cell Biol 85: 246-251.
25. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M (2010) Endocrine aspects of male sexual dysfunctions. J Sex Med 7: 1627-1656. doi: 10. 1111/j. 1743-6109. 2010. 01780. x.